AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MICROBA LIFE SCIENCES LTD

0.049

0.000

Volume:32.18K

Turnover:2K

Market Cap:35.14M

PE:-1.42

High:0.049

Open:0.049

Low:0.048

Close:0.049

52wk High:0.105

52wk Low:0.036

Shares:717.12M

Float Shares:285.73M

Volume Ratio:0.04

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.034

EPS(LYR):-0.034

ROE:-72.87%

ROA:-29.09%

PB:1.44

PE(LYR):-1.42

Loading ...

Overview Company News Filings

Microba Life Sciences Ltd-Appointment of Interim Chief Executive Officer

THOMSON REUTERS

Microba Life Sciences - CEO Luke Reid on Medical Leave

THOMSON REUTERS

Microba Life Sciences - Appoints Geoffrey Cockerill as Interim CEO Commencing Sept 29, 2026

THOMSON REUTERS

Genetic Signatures - Microba Shareholders to Receive 0.654 New Gss Shares Per Microba Share

THOMSON REUTERS

Genetic Signatures - Deal Equates to Issue of 469 Mln New Gss Shares

THOMSON REUTERS

Genetic Signatures - Co and Microba Life Sciences Agree to Principal Commercial Terms for Merger

THOMSON REUTERS

Genetic Signatures - Proposed Merger to be Funded Through Issue of Gss Securities, no Cash Consideration

THOMSON REUTERS

Microba Life Sciences - There were no Dividends Paid, Recommended or Declared During the Current Financial Period

THOMSON REUTERS

Microba Life Sciences - FY Revenues from Ordinary Activities A$14.8 Mln

THOMSON REUTERS

Australia's Genetic Signatures Climbs on Potential Merger with Microba

Genetic Signatures - Combined Group to Benefit from Streamlined Cost Base and Potential Accelerated Growth

THOMSON REUTERS

Microba Life Sciences Insiders Forfeit On 21% Gains After Selling Stock

Simply Wall St.

Microba Life Sciences Says Microba Signs Multi-year Synlab Agreement

Microba Life Sciences Ltd-microba Signs Multi-year Synlab Agreement

THOMSON REUTERS

Microba Life Sciences - Q4 FY26 Total Revenue A$4.07 Mln, up 21% Qoq, Down 2% Year-on-year

THOMSON REUTERS

BUZZ-Australia's Microba Life Sciences slumps to record low on discounted placement

BRIEF-Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share

Microba Life Sciences Ltd-Extension of Voluntary Suspension

THOMSON REUTERS

BRIEF-Microba Life Sciences Seeks Trading Halt

Microba Life Sciences - Trading Halt Requested Due to Material Capital Raise and Break Even Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/MAP.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","market":"AU","secType":"STK","nameCN":"MICROBA LIFE SCIENCES LTD","latestPrice":0.049,"timestamp":1790835120000,"preClose":0.049,"halted":0,"volume":32179,"delay":0,"changeRate":0,"nameEN":"MICROBA LIFE SCIENCES LTD","floatShares":285729013,"shares":717117274,"eps":-0.034499,"marketStatus":"Not Yet Opened","change":0,"latestTime":"10-01 16:12:00 AEST","open":0.049,"high":0.049,"low":0.048,"amount":1566,"amplitude":0.020408,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.034499,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":0,"adr":0,"listingDate":1648994400000,"exchange":"ASX","adjPreClose":0.049,"openAndCloseTimeList":[[1790812800000,1790834400000]],"volumeRatio":0.04128755481548713,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MAP.AU","preClose":0.049,"auctionPrice":0.049,"auctionVolume":20000,"auction":3,"marketStatus":"盘后竞价","timestamp":1790834774297}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","floatShares":285729013,"roa":"-29.09%","roe":"-72.87%","lyrEps":-0.0345,"volumeRatio":0.04128755481548713,"shares":717117274,"dividePrice":0,"high":0.049,"amplitude":0.020408,"preClose":0.049,"low":0.048,"week52Low":0.036,"pbRate":"1.44","psRate":"2.38","week52High":0.105,"institutionHeld":0,"latestPrice":0.049,"eps":-0.034499,"divideRate":0,"volume":32179,"delay":0,"ttmEps":-0.034499,"open":0.049,"prevYearClose":0.076,"prevWeekClose":0.051,"prevMonthClose":0.049,"prevQuarterClose":0.049,"fiveDayClose":0.05,"twentyDayClose":0.055,"sixtyDayClose":0.04,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAP.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-15","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1784073600000,"name":null,"time":"","dateTimestamp":1784037600000,"actualEps":null},{"date":"2026-04-29","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777420800000,"name":null,"time":"","dateTimestamp":1777384800000,"actualEps":null},{"date":"2026-01-28","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null},{"date":"2025-10-27","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761519600000,"name":null,"time":"","dateTimestamp":1761483600000,"actualEps":null},{"market":"AU","date":"2025-07-22","symbol":"MAP.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1753106400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAP.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670789415","title":"Microba Life Sciences Ltd-Appointment of Interim Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670789415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670789415?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:42","pubTimestamp":1790289751,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUE4HKKQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670415786","title":"Microba Life Sciences - CEO Luke Reid on Medical Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2670415786","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670415786?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:42","pubTimestamp":1790289751,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUE4HKKQL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670157854","title":"Microba Life Sciences - Appoints Geoffrey Cockerill as Interim CEO Commencing Sept 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670157854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670157854?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:42","pubTimestamp":1790289751,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUE4HKKQL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669962981","title":"Genetic Signatures - Microba Shareholders to Receive 0.654 New Gss Shares Per Microba Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2669962981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669962981?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","MAP.AU","BK7501","BK7124","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669297196","title":"Genetic Signatures - Deal Equates to Issue of 469 Mln New Gss Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669297196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669297196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7048","BK7124","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196293","title":"Genetic Signatures - Co and Microba Life Sciences Agree to Principal Commercial Terms for Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196293?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7124","BK7048","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196218","title":"Genetic Signatures - Proposed Merger to be Funded Through Issue of Gss Securities, no Cash Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196218?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7501","BK7048","MAP.AU","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663260430","title":"Microba Life Sciences - There were no Dividends Paid, Recommended or Declared During the Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663260430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663260430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:36","pubTimestamp":1788143813,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663026048","title":"Microba Life Sciences - FY Revenues from Ordinary Activities A$14.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2663026048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663026048?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:36","pubTimestamp":1788143813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44P21B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662767137","title":"Australia's Genetic Signatures Climbs on Potential Merger with Microba","url":"https://stock-news.laohu8.com/highlight/detail?id=2662767137","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662767137?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:40","pubTimestamp":1787722801,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures climbs on potential merger with Microba** Shares of Australia's Genetic SignaturesGSS.AXrise as much as 6.9% to A$0.0855, hitting their highest level since May 4** ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4N44N0AX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7048","BK7124","GSS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662476825","title":"Genetic Signatures - Combined Group to Benefit from Streamlined Cost Base and Potential Accelerated Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662476825","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662476825?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:30","pubTimestamp":1787700640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUENDSZ2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7048","GSS.AU","BK7501","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660161494","title":"Microba Life Sciences Insiders Forfeit On 21% Gains After Selling Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2660161494","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660161494?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:40","pubTimestamp":1787096440,"startTime":"0","endTime":"0","summary":"Despite the fact that Microba Life Sciences Limited (ASX:MAP) stock rose 21% last week, insiders who sold AU$213k worth...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-map/microba-life-sciences-shares/news/microba-life-sciences-insiders-forfeit-on-21-gains-after-sel","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-map/microba-life-sciences-shares/news/microba-life-sciences-insiders-forfeit-on-21-gains-after-sel","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652650322","title":"Microba Life Sciences Says Microba Signs Multi-year Synlab Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652650322","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652650322?lang=en_us&edition=fundamental","pubTime":"2026-07-20 09:37","pubTimestamp":1784511454,"startTime":"0","endTime":"0","summary":"BRIEF-Microba Life Sciences Says Microba Signs Multi-Year Synlab AgreementJuly 20 (Reuters)-Microba Life Sciences LtdMAP.AX:MICROBA SIGNS MULTI-YEAR SYNLAB AGREEMENTSYNLAB AND MICROBA SIGN AGREEMENT TO ADVANCE MICROBIOME DIAGNOSTICS IN EUROPE AND LATIN AMERICAFurther company coverage:MAP.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUE920XCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652268546","title":"Microba Life Sciences Ltd-microba Signs Multi-year Synlab Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652268546?lang=en_us&edition=fundamental","pubTime":"2026-07-20 07:05","pubTimestamp":1784502302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nTUE920XCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651649147","title":"Microba Life Sciences - Q4 FY26 Total Revenue A$4.07 Mln, up 21% Qoq, Down 2% Year-on-year","url":"https://stock-news.laohu8.com/highlight/detail?id=2651649147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651649147?lang=en_us&edition=fundamental","pubTime":"2026-07-16 07:04","pubTimestamp":1784156661,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H1AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642253294","title":"BUZZ-Australia's Microba Life Sciences slumps to record low on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642253294","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642253294?lang=en_us&edition=fundamental","pubTime":"2026-06-12 09:19","pubTimestamp":1781227152,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Microba Life Sciences slumps to record low on discounted placement** Shares of Microba Life Sciences MAP.AX fall 28.6% to A$0.045, marking a record low level** Health sciences co secu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nL4N42K02A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642587482","title":"BRIEF-Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2642587482","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642587482?lang=en_us&edition=fundamental","pubTime":"2026-06-12 08:46","pubTimestamp":1781225205,"startTime":"0","endTime":"0","summary":"BRIEF-Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per ShareJune 12 (Reuters) - Microba Life Sciences Ltd MAP.AX:A$5 MILLION PLACEMENT SECURED AT A$0.05 PER SHAREFurther company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42J110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642471743","title":"Microba Life Sciences Ltd-Extension of Voluntary Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2642471743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642471743?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:45","pubTimestamp":1781131535,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUE4CDV88:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640823924","title":"BRIEF-Microba Life Sciences Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2640823924","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640823924?lang=en_us&edition=fundamental","pubTime":"2026-06-03 08:01","pubTimestamp":1780444876,"startTime":"0","endTime":"0","summary":"BRIEF-Microba Life Sciences Seeks Trading Halt June 3 (Reuters) - Microba Life Sciences Ltd MAP.AX:TRADING HALT REQUESTED DUE TO MATERIAL CAPITAL RAISE AND BREAK EVEN UPDATEFurther company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42A0OA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640292485","title":"Microba Life Sciences - Trading Halt Requested Due to Material Capital Raise and Break Even Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2640292485","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640292485?lang=en_us&edition=fundamental","pubTime":"2026-06-03 08:00","pubTimestamp":1780444857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42A0OA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}